Tower Research Capital LLC (TRC) - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V116. A total of 15 filers reported holding EFFECTOR THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$0
-100.0%
230.0%0.00%
Q1 2024$3
+50.0%
230.0%0.00%
Q4 2023$20.0%230.0%0.00%
Q3 2023$2
-50.0%
230.0%0.00%
Q2 2023$4230.0%0.00%
Q1 2023$0230.0%0.00%
Q4 2022$0230.0%0.00%
Q3 2022$0230.0%0.00%
Q2 2022$0230.0%0.00%
Q1 2022$0230.0%0.00%
Q4 2021$0230.0%0.00%
Q3 2021$0230.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
MARINER INVESTMENT GROUP LLC 22,935$37,0000.10%
ARISTEIA CAPITAL, L.L.C. 1,750,000$2,844,0000.05%
Monashee Investment Management LLC 133,332$213,0000.04%
MMCAP International Inc. SPC 150,867$241,0000.02%
Alpine Global Management, LLC 40,450$65,0000.02%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 323,245$517,0000.01%
CVI Holdings, LLC 88,462$144,0000.01%
LITTLEJOHN & CO LLC 16,666$27,0000.01%
WHITEBOX ADVISORS LLC 218,447$350,0000.01%
EQUITEC PROPRIETARY MARKETS, LLC 12,700$20,0000.00%
View complete list of EFFECTOR THERAPEUTICS INC shareholders